Ikarian Capital, LLC Spdr Ser Tr Spdr S&P Biotech E Call Options Transaction History

Ikarian Capital, LLC

$573 Million
Q3 2024

Call Options

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$76.72 - $85.66 $7.67 Million - $8.57 Million	100,000 New	100,000 $8.3 Million
Q1 2022 May 13, 2022	BUY	$81.07 - $115.44 $68.4 Million - $97.3 Million	843,200 Added 912.55%	935,600 $84.1 Million
Q4 2021 Feb 14, 2022	SELL	$108.77 - $134.15 $22.6 Million - $27.8 Million	-207,600 Reduced 69.2%	92,400 $10.3 Million
Q3 2021 Nov 15, 2021	BUY	$118.69 - $138.49 $35.6 Million - $41.5 Million	300,000 New	300,000 $37.7 Million
Q2 2021 Aug 16, 2021	SELL	$122.48 - $139.69 $42.9 Million - $48.9 Million	-350,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$129.36 - $173.99 $36.2 Million - $48.7 Million	280,000 Added 400.0%	350,000 $47.5 Million
Q4 2020 Feb 12, 2021	SELL	$110.36 - $151.14 $19.9 Million - $27.2 Million	-180,000 Reduced 72.0%	70,000 $9.86 Million
Q1 2020 May 15, 2020	BUY	$65.95 - $98.35 $16.5 Million - $24.6 Million	250,000 New	250,000 $19.4 Million

Others Institutions Holding XBI

# of Institutions

927

Shares Held

101M

Call Options Held

28.4M

Put Options Held

33.4M

Goldman Sachs Group Inc New York, NY

12.7M
Shares

$1.21 Billion
0.21% of portfolio
Jpmorgan Chase & CO New York, NY

12.3M
Shares

$1.16 Billion
0.1% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

9.23M
Shares

$873 Million
2.24% of portfolio
Morgan Stanley New York, NY

8.02M
Shares

$759 Million
0.06% of portfolio
Citigroup Inc

7.75M
Shares

$733 Million
0.45% of portfolio

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.